Huntington National Bank Albireo Pharma, Inc. Transaction History

Huntington National Bank

$13.5 Billion
Q3 2024

A detailed history of Huntington National Bank transactions in Albireo Pharma, Inc. stock. As of the latest transaction made, Huntington National Bank holds 1 shares of ALBO stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 1 -0.0%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$0.0 - $44.95 $0 - $36,139	-804 Reduced 99.88%	1 $0
Q4 2022 Feb 09, 2023	SELL	$18.01 - $23.78 $1,440 - $1,902	-80 Reduced 9.04%	805 $17,000
Q3 2022 Nov 07, 2022	BUY	$16.32 - $26.37 $3,361 - $5,432	206 Added 30.34%	885 $17,000
Q2 2022 Aug 09, 2022	BUY	$18.54 - $37.29 $10,641 - $21,404	574 Added 546.67%	679 $13,000
Q1 2022 May 10, 2022	SELL	$23.94 - $33.74 $47 - $67	-2 Reduced 1.87%	105 $3,000
Q4 2021 Jan 21, 2022	BUY	$21.19 - $31.29 $2,267 - $3,348	107 New	107 $2,000

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Account

Huntington National Bank Albireo Pharma, Inc. Transaction History